Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and ...

The era of digital twins offers a future where deep biology, AI and real-world data combine to make medicine more personal, ...

Insitro’s co-founder is betting on the fact that real progress in biotech requires more than clever algorithms.

The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a ...

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, ...

A strong healthcare ecosystem attracts talent, supports suppliers and generates tax revenue, giving every business in the ...

We develop cutting-edge software and AI solutions for small molecule design, optimization and data analysis. Our mission is ...

Type 1 diabetes remains a persistent health-care burden despite substantial advances in care. Its preclinical disease course ...